Comparative Study of Adaptive Molecular Evolution in Different Human Immunodeficiency Virus Groups and Subtypes

Journal of Virology

Volumn 78, Issue 4, 2004, Pages 1962-1970

  Choisy, Marc ^a   Woelk, Christopher H ^b   Guégan, Jean François ^a   Robertson, David L ^c  

^a CNRS   (France)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; EPITOPE;

ADAPTATION; ARTICLE; CODON; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ENVELOPE GENE; GENE LOCATION; GENE STRUCTURE; GENETIC ANALYSIS; GENETIC SELECTION; GLYCOSYLATION; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; IMMUNE RESPONSE; MAXIMUM LIKELIHOOD METHOD; MOLECULAR EVOLUTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; QUANTITATIVE GENETICS; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; STRUCTURAL GENE; VIRUS GENE; VIRUS STRAIN;

ADAPTATION, PHYSIOLOGICAL; AMINO ACID SEQUENCE; EPITOPES, T-LYMPHOCYTE; EVOLUTION, MOLECULAR; GENE PRODUCTS, ENV; GENES, ENV; GLYCOSYLATION; HIV INFECTIONS; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; SELECTION (GENETICS);

EID: 0842326022     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.4.1962-1970.2004     Document Type: Article

References (40)

1. Anisimova, M., J. P. Bielawski, and Z. Yang. 2002. Accuracy and power of the Bayes prediction of amino acid sites under positive selection. Mol. Biol. Evol. 19:950-958.
2. Anisimova, M., J. P. Bielawski, and Z. Yang. 2001. Accuracy and power of the likelihood ratio test in detecting adaptive molecular evolution. Mol. Biol. Evol. 18:1585-1592.
3. Ayouba, A., S. Souquieres, B. Njinku, P. M. Martin, M. C. Muller-Trutwin, P. Roques, F. Barre-Sinoussi, P. Mauclere, F. Simon, and E. Nerrienet. 2000. HIV-1 group N among HIV-1-seropositive individuals in Cameroon. AIDS 14:2623-2625.
4. Bonhoeffer, S., E. C. Holmes, and M. A. Nowak. 1995. Causes of HIV diversity. Nature 376:125.
5. Botarelli, P., B. A. Houlden, N. L. Haigwood, C. Servis, D. Montagna, and S. Abrignani. 1991. N-glycosylation of HIV-gp120 may constrain recognition by T lymphocytes. J. Immunol. 147:3128-3132.
6. Gao, F., E. Bailes, D. L. Robertson, Y. Chen, C. M. Rodenburg, S. F. Michael, L. B. Cummins, L. O. Arthur, M. Peeters, G. M. Shaw, P. M. Sharp, and B. H. Hahn. 1999. Origin of HIV-1 in the chimpanzee Pan troglodytes. Nature 397:436-441.
7. Gaschen, B., J. Taylor, K. Yusim, B. Foley, F. Gao, D. Lang, V. Novitsky, B. Haynes, B. Hahn, T. Bhattacharya, and B. Korber. 2002. Diversity considerations in HIV-1 vaccine selection. Science 296:2354-2360.
8. Hahn, B. H., G. M. Shaw, K. M. De Cock, and P. M. Sharp. 2000. AIDS as a zoonosis: scientific and public health implications. Science 287:607-614.
9. Hansen, J. E., O. Lund, N. Tolstrup, A. A. Gooley, K. L. Williams, and S. Brunak. 1998. NetOglyc: prediction of mucin type O-glycosylation sites based on sequence context and surface accessibility. Glycoconj. J. 15:115-130.
10. IIIB BP120 peptide RP135. Biochemistry 36:10846-10856.
11. Korber, B., C. Brander, B. Haynes, R. Koup, C. Kuiken, J. P. Moore, B. D. Walker, and D. I. Watkins. 2000. HIV molecular immunology. Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, N.Mex.
12. Kuiken, C., B. Foley, B. Hahn, P. A. Marx, F. McCutchan, J. W. Mellors, J. L. Mullins, S. Wolinsky, and B. Korber. 2000. HIV sequence compendium. Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, N.Mex.
13. Kwong, P. D., M. L. Doyle, D. J. Casper, C. Cicala, S. A. Leavitt, S. Majeed, T. D. Steenbeke, M. Venturi, I. Chaiken, M. Fung, H. Katinger, P. W. Parren, J. Robinson, D. Van Ryk, L. Wang, D. R. Burton, E. Freire, R. Wyatt, J. Sodroski, W. A. Hendrickson, and J. Arthos. 2002. HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites. Nature 420:678-682.
14. Liedtke, S., R. Geyer, and H. Geyer. 1997. Host-cell-specific glycosylation of HIV-2 envelope glycoprotein. Glycoconj. J. 14:785-793.
15. Moore, C. B., M. John, I. R. James, F. T. Christiansen, C. S. Witt, and S. A. Mallal. 2002. Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 296:1439-1443.
16. Nickle, D. C., M. A. Jensen, G. S. Gottlieb, D. Shriner, G. H. Learn, A. G. Rodrigo, and J. I. Mullins. 2003. Consensus and ancestral state HIV vaccines. Science 299:1515-1518.
17. Nielsen, R., and Z. Yang. 1998. Likelihood models for detecting positively selected amino-acid sites and applications to the HIV-1 envelope gene. Genetics 148:929-936.
18. Pantophlet, R., E. Ollmann Saphire, P. Poignard, P. W. Parren, I. A. Wilson, and D. R. Burton. 2003. Fine mapping of the interaction of neutralizing and nonneutralizing monoclonal antibodies with the CD4 binding site of human immunodeficiency virus type 1 gp120. J. Virol. 77:642-658.
19. Papandreou, M. J., T. Idziorek, R. Miquelis, and E. Fenouillet. 1996. Glycosylation and stability of mature HIV envelope glycoprotein conformation under various conditions. FEBS Lett. 379:171-176.
20. Pillai, S., B. Good, D. D. Richman, and J. Corbeil. 2003. A new perspective on V3 phenotype prediction. AIDS Res. Hum. Retrovir. 19:145-149.
21. Pollakis, G., S. Kang, A. Kliphuis, M. I. M. Chalaby, J. Goudsmit, and W. A. Paxton. 2001. N-linked glycosylation of the HIV type 1 gp120 envelope glycoprotein as a major determinant of CCR5 and CXCR4 coreceptor utilization. J. Biol. Chem. 276:13433-13441.
22. Price, D. A., P. J. R. Goulder, P. Klernerman, A. K. Sewell, P. J. Easterbrook, M. Troop, C. R. M. Bangham, and R. E. Phillips. 1997. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc. Natl. Acad. Sci. USA 94:1890-1895.
23. Rambaut, A., D. L. Robertson, O. G. Pybus, M. Peeters, and E. C. Holmes. 2001. Phylogeny and the origin of HIV-1. Nature 410:1047-1048.
24. Robertson, D. L., J. P. Anderson, J. A. Bradac, J. K. Carr, B. Foley, R. K. Funkhouser, F. Gao, B. H. Hahn, M. L. Kalish, C. Kuiken, G. H. Learn, T. Leitner, F. E. McCutchan, S. Osmanov, M. Peeters, D. Pieniazek, M. Salminen, P. M. Sharp, S. Wolinsky, and B. Korber. 2000. HIV-1 nomenclature proposal. Science 288:55-57.
25. Roques, P., D. L. Robertson, S. Souquiere, F. Damond, A. Ayouba, I. Farfara, C. Depienne, E. Nerrienet, D. Dormont, F. Brun-Vezinet, F. Simon, and P. Mauclere. 2002. Phylogenetic analysis of 49 newly derived HIV-1 group O strains: high viral diversity but no group M-like subtype structure. Virology 302:259-273.
26. Sokal, R. R., and F. J. Rohlf. 1981. Biometry. W. H. Freeman and Company, New York, N.Y.
27. Swofford, D. L. 2000. PAUP*: phylogenetic analysis using parsimony (* and other methods). Version 4.0b6. Sinauer Associates, Sunderland, Mass.
28. Wei, X., J. M. Decker, S. Wang, H. Hui, J. C. Kappes, X. Wu, J. F. Salazar-Gonzalez, M. G. Salazar, J. M. Kilby, M. S. Saag, N. L. Komarova, M. A. Nowak, B. H. Hahn, P. D. Kwong, and G. M. Shaw. 2003. Antibody neutralization and escape by HIV-1. Nature 422:307-312.
29. Woelk, C. H., and E. C. Holmes. 2002. Reduced positive selection in vectorborne RNA viruses. Mol. Biol. Evol. 19:2333-2336.
30. Wolinsky, S. M., B. T. Korber, A. U. Neumann, M. Daniels, K. J. Kunstman, A. J. Whetsell, M. R. Furtado, Y. Cao, D. D. Ho, and J. T. Safrit. 1996. Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection. Science 272:537-542.
31. Wu, L., N. P. Gerard, R. Wyatt, H. Choe, C. Parolin, N. Ruffing, A. Borsetti, A. A. Cardoso, E. Desjardin, W. Newman, C. Gerard, and J. Sodroski. 1996. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature 384:179-183.
32. Wyatt, R., P. D. Kwong, E. Desjardins, R. W. Sweet, J. Robinson, W. A. Hendrickson, and J. G. Sodroski, 1998. The antigenic structure of the HIV gp120 envelope glycoprotein. Nature 393:705-711.
33. Yamaguchi, J., A. S. Vallari, P. Swanson, P. Bodelle, L. Kaptue, C. Ngansop, L. Zekeng, L. G. Gurtler, S. G. Devare, and C. A. Brennan. 2002. Evaluation of HIV type 1 group O isolates: identification of five phylogenetic clusters. AIDS Res. Hum. Retrovir. 18:269-282.
34. Yamaguchi, Y., and T. Gojobori. 1997. Evolutionary mechanisms and population dynamics of the third variable envelope region HIV within single hosts. Proc. Natl. Acad. Sci. USA 94:1264-1269.
35. Yamaguchi-Kabata, Y., and T. Gojobori. 2000. Reevaluation of amino acid variability of the human immunodeficiency virus type 1 gp120 envelope glycoprotein and prediction of new discontinuous epitopes. J. Virol. 74:4335-4350.
36. Yang, Z. 1997. PAML: a program package for the phylogenetic analysis by maximum likelihood. Comput. Appl. Biosci. 13:555-556.
37. Yang, Z., and J. P. Bielawski. 2000. Statistical methods for detecting molecular adaptation. Trends Ecol. Evol. 15:496-503.
38. Yang, Z. H., R. Nielsen, N. Goldman, and A. M. K. Pedersen. 2000. Codon-substitution models for heterogeneous selection pressure at amino acid sites. Genetics 155:431-449.
39. Yusim, K., C. Kesmir, B. Gaschen, M. M. Addo, M. Altfeld, S. Brunak, A. Chigaev, V. Detours, and B. T. Korber. 2002. Clustering patterns of cytotoxic T-lymphocyte epitopes in human immunodeficiency virus type 1 (HIV-1) proteins reveal imprints of immune evasion on HIV-1 global variation. J. Virol. 76:8757-8768.
40. Zanotto, P. M., E. G. Kallas, R. F. de Souza, and E. C. Holmes. 1999. Genealogical evidence for positive selection in the nef gene of HIV-1. Genetics 153:1077-1089.